← All trials
NCT00395031
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2003
- Primary completion
- Jan 1, 2010
- Completion date
- Jan 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 57
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Manhattan Psychiatric CenterLead sponsor
- PfizerCollaborator
- New York UniversityOverall official - principal investigator
- New York UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.